Connor Clark & Lunn Investment Management Ltd. Acquires Shares of 108,521 Nature’s Sunshine Products, Inc. $NATR

Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) in the 2nd quarter, HoldingsChannel reports. The fund acquired 108,521 shares of the company’s stock, valued at approximately $2,366,000.

Other institutional investors also recently modified their holdings of the company. BlackRock Inc. bought a new stake in shares of Nature’s Sunshine Products in the second quarter worth about $21,561,000. Dimensional Fund Advisors LP raised its position in Nature’s Sunshine Products by 2.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 913,791 shares of the company’s stock valued at $14,181,000 after purchasing an additional 20,037 shares during the last quarter. Vanguard Group Inc. raised its position in Nature’s Sunshine Products by 15.3% during the 3rd quarter. Vanguard Group Inc. now owns 803,104 shares of the company’s stock valued at $12,464,000 after purchasing an additional 106,688 shares during the last quarter. Kennedy Capital Management LLC lifted its holdings in Nature’s Sunshine Products by 14.6% in the 3rd quarter. Kennedy Capital Management LLC now owns 675,764 shares of the company’s stock worth $10,488,000 after buying an additional 86,128 shares during the period. Finally, Renaissance Technologies LLC grew its position in shares of Nature’s Sunshine Products by 1.5% in the 1st quarter. Renaissance Technologies LLC now owns 531,924 shares of the company’s stock worth $12,761,000 after buying an additional 7,827 shares during the last quarter. 79.40% of the stock is currently owned by hedge funds and other institutional investors.

Nature’s Sunshine Products Stock Up 2.1%

Shares of NATR stock opened at $14.21 on Friday. The business’s fifty day moving average is $18.99 and its 200 day moving average is $22.43. The stock has a market cap of $250.10 million, a price-to-earnings ratio of 14.07 and a beta of 0.88. Nature’s Sunshine Products, Inc. has a twelve month low of $12.97 and a twelve month high of $28.14.

Nature’s Sunshine Products (NASDAQ:NATR) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.27 by ($0.06). Nature’s Sunshine Products had a net margin of 3.68% and a return on equity of 12.88%. The firm had revenue of $116.99 million for the quarter, compared to analysts’ expectations of $123.70 million.

Insider Buying and Selling at Nature’s Sunshine Products

In related news, EVP Kevin R. Herbert sold 2,000 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $20.68, for a total value of $41,360.00. Following the completion of the transaction, the executive vice president directly owned 48,866 shares in the company, valued at $1,010,548.88. This trade represents a 3.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Bryant J. Yates sold 11,968 shares of Nature’s Sunshine Products stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $19.90, for a total transaction of $238,163.20. Following the transaction, the executive vice president directly owned 77,446 shares of the company’s stock, valued at approximately $1,541,175.40. This trade represents a 13.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have purchased 161,389 shares of company stock valued at $2,612,536 and have sold 23,681 shares valued at $480,000. 3.10% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Canaccord Genuity Group reduced their target price on Nature’s Sunshine Products from $37.00 to $36.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. DA Davidson cut their price target on shares of Nature’s Sunshine Products from $33.00 to $25.00 and set a “buy” rating on the stock in a report on Monday, August 10th. Wall Street Zen downgraded shares of Nature’s Sunshine Products from a “buy” rating to a “hold” rating in a research report on Sunday, August 16th. Finally, Weiss Ratings lowered shares of Nature’s Sunshine Products from a “hold (c+)” rating to a “hold (c)” rating in a report on Tuesday, August 18th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $30.50.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.